Related references
Note: Only part of the references are listed.Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for Minimization
Hongdo Do et al.
CLINICAL CHEMISTRY (2015)
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
Stephen Q. Wong et al.
BMC MEDICAL GENOMICS (2014)
High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation Sequencing
Richard Bourgon et al.
CLINICAL CANCER RESEARCH (2014)
Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Cancer Specimens
Colin C. Pritchard et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Reducing Sequence Artifacts in Amplicon-Based Massively Parallel Sequencing of Formalin-Fixed Paraffin-Embedded DNA by Enzymatic Depletion of Uracil-Containing Templates
Hongdo Do et al.
CLINICAL CHEMISTRY (2013)
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
Marcel Wiesweg et al.
EUROPEAN JOURNAL OF CANCER (2013)
Clinical Validation of a Next-Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-Related Genes
Rajesh R. Singh et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
Richard W. Tothill et al.
JOURNAL OF PATHOLOGY (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations
Filip Janku et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
An integrated map of genetic variation from 1,092 human genomes
David M. Altshuler et al.
NATURE (2012)
A Novel Classification of Lung Cancer into Molecular Subtypes
Lisandra West et al.
PLOS ONE (2012)
Human Melanoma Metastasis in NSG Mice Correlates with Clinical Outcome in Patients
Elsa Quintana et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
Nikhil Wagle et al.
CANCER DISCOVERY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor
William McLaren et al.
BIOINFORMATICS (2010)
International network of cancer genome projects
Thomas J. Hudson et al.
NATURE (2010)
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Molecular classification of solid tumours: towards pathway-driven therapeutics
C. Swanton et al.
BRITISH JOURNAL OF CANCER (2009)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
Share Paper
